| abstract |
The present invention provides antibodies that bind to protease activated receptor-2 (PAR-2) and methods of using the same. In accordance with certain embodiments of the present invention, the antibodies are fully human antibodies that bind to human PAR-2. The present invention is particularly useful for the treatment of diseases and disorders associated with one or more PAR-2 biological activities, including the treatment of pain disorders, inflammatory diseases and gastrointestinal disorders. |